Key facts
- It has raised $1.4M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Bossa Invest, ACE Ventures (Commercial Services), Garan Ventures, Sirius Venture Capital, Uruau Participações.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Medipreço
- ·The full record, as it builds
Funding rounds
No funding rounds for Medipreço are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medipreço
Developer of a digital health platform designed to help employees get access to cheap medicines and wellness products. The company's platform aids in promoting adherence to treatments through low-cost access to medicines and provides personalized online support to deal with chronic and mental health conditions, enabling patients to easily find the fairest medication prices and reduce the direct and indirect cost of illness.
- Sector
- Healthcare
- HQ
- Brasilia, Brazil
- Founded
- 2017
- Employees
- 19
- Website
- site.medipreco.com.br/
- Ownership
- Privately Held (backing)
Medipreço doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medipreço shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medipreço in its N-PORT filings yet. We sweep new filings monthly.